Lumiracoxib Completed Phase 3 Trials for Osteoarthritis in the Hip Joint Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00154219Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis